Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Pembrolizumab
Stereotactic Body Radiation Therapy (5 days)
+1 more
Locations
3
United States
University of San Diego
San Diego, California, United States
Portland Providence Medical Center
Portland, Oregon, United States
Providence St. Vincent Medical Center
Portland, Oregon, United States
Start Date
January 11, 2022
Primary Completion Date
January 11, 2027
Completion Date
January 11, 2031
Last Updated
March 10, 2025
NCT05039801
NCT06980038
NCT06806852
NCT04585750
NCT06636188
NCT07457346
Lead Sponsor
Providence Health & Services
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions